FDA: Don’t Mix Opioid Addiction Medication with Anti-Anxiety Drugs


The Food and Drug Administration (FDA) issued a new warning about mixing medication to treat opioid addiction with anti-anxiety drugs.

Both types of drugs slow breathing and brain activity.

Combining opioid addiction medications with anti-anxiety drugs can lead to difficulty breathing, coma or death, the agency said. In addition to anti-anxiety drugs such as Valium and Xanax, other drugs that should not be combined with opioid addiction medication include Ambien and Lunesta for insomnia, muscle relaxers Soma and Zanaflex, and antipsychotic drugs Abilify, Invega, and Saphris, the Associated Press reports.

Buprenorphine and methadone, also known as medication-assisted treatment, reduce opioid cravings and withdrawal without producing a high. The FDA is requiring changes to medication-assisted treatment drug labels. The new labels recommend that health care providers develop a treatment plan that closely monitors any simultaneous use of these drugs.

Rate this blog entry:

Related Posts


Dear Friend of NCADD ...
It takes courage, determination and strength to avoid alcohol and drugs or to seek help and overcome addiction. We want to do everything in our power to provide the tools and support to help those on this journey. Without question, this is the most important journey of their lives and your support makes a huge difference in its outcome!
On behalf of all those on the journey to recovery, and of all those waiting to start that journey, we thank you.
Donate Now